The biotechnology industry's recent full-court press to let firms owned by venture capitalists qualify for federal small-business grants has found an ally in Dr. Elias Zerhouni, head of the National Institutes of Health. Although most NIH awards go to small biotechnology companies, an SBA judge ruled in 2003 that companies controlled by venture capital firms are disqualified. Thus, many biotech companies cannot get grants because they tend to be majority-owned by such venture capital firms.
July 29, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Description:NFSA has a great opportunity for a Labor Relations Associate and Junior Counsel. This position will support NFSA's collective ba...
McCarter & English, LLP is seeking litigation attorneys for our Newark, NJ offices. Candidates must have 3-6 years of law firm experien...
McCarter & English, LLP is actively seeking a corporate associate for its office located in Boston, MA. Candidate must have 2 - 5 years ...
